Prime Medicine, Inc. (PRME) SEC Filings — 2025
15 SEC filings for Prime Medicine, Inc. (PRME) in 2025.
Filings
- Prime Medicine Narrows Q3 Loss, Boosts Cash with $138M Offering — 10-Q · Nov 7, 2025
- Prime Medicine Files 8-K — 8-K · Sep 8, 2025
- Prime Medicine's Losses Widen Amid Heavy R&D Spend — 10-Q · Aug 7, 2025
- Prime Medicine Reports Director, Officer, and Shareholder Votes — 8-K · Aug 5, 2025
- Prime Medicine, Inc. Enters Material Definitive Agreement — 8-K · Jul 31, 2025
- Prime Medicine Files 8-K on Operations and Financials — 8-K · Jul 30, 2025
- Prime Medicine Appoints New Directors, Adjusts Executive Pay — 8-K · Jul 15, 2025
- Prime Medicine Seeks Shareholder Nod for Stock Option Repricing — DEF 14A · Jul 14, 2025
- Prime Medicine Files 8-K on Shareholder Votes and Exhibits — 8-K · Jun 5, 2025
- Prime Medicine Reports Director Changes and Officer Appointments — 8-K · May 19, 2025
- Prime Medicine Files Q1 2025 10-Q — 10-Q · May 8, 2025
- Prime Medicine Files 2024 Proxy Statement — DEF 14A · Apr 22, 2025
- Prime Medicine Files 8-K — 8-K · Mar 18, 2025
- Prime Medicine, Inc. 10-K Filing — 10-K · Feb 28, 2025
- Prime Medicine Files 8-K — 8-K · Jan 13, 2025